BCHE and Alzheimer disease: Recent cognitive enhancers for pharmacologic treatment for AD include the cholinesterase inhibitor drug class (donepezil, galantamine and rivastigmine), as well as memantine, a N-methyl-D-aspartic acid (NMDA) receptor antagonist [9].